Sunlenca

Medicinal product

(Invented) name

Sunlenca

Active substance (s)

Lenakapaviras

Strength

300 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AX31, lenacapavir

Marketing authorisation holder

Gilead Sciences Ireland UC, Airija

Date of authorisation

2022-08-17

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Lenakapaviras	300 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
109259	95365	1095365	lizdinė plokštelė	N5		Receptinis	EU/1/22/1671/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-08-17	Registruotas